reference/12579071

Predicate	Object
contentType	Journal Article\|Review
endingPage	2141
issn	0012-6667 1179-1950
issueIdentifier	18
pageRange	2125-2141
publicationName	Drugs
startingPage	2125
bibliographicCitation	Curran MP, Perry CM. Cabergoline : a review of its use in the treatment of Parkinson's disease. Drugs. 2004;64(18):2125–41. doi: 10.2165/00003495-200464180-00015. PMID: 15341508.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beadbdbb8a7761ddf9a778e705a601c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_998a2c21fc32486745164d15432c01df
date	200409
identifier	https://pubmed.ncbi.nlm.nih.gov/15341508 https://doi.org/10.2165/00003495-200464180-00015
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453 https://portal.issn.org/resource/ISSN/1179-1950 https://portal.issn.org/resource/ISSN/0012-6667
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/
title	Cabergoline : a review of its use in the treatment of Parkinson's disease
discusses	http://id.nlm.nih.gov/mesh/M0007652 http://id.nlm.nih.gov/mesh/M0001494 http://id.nlm.nih.gov/mesh/M0136060
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598488 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857537

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46508571 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135989394 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1813

Total number of triples: 35.